Tag: liver tumour
Delcath Systems receives US FDA authorisation for Hepzato phase two clinical...
Delcath Systems has announced that the US Food and Drug Administration (FDA) has completed its 30-day review of the company's investigational new drug (IND)...
HistoSonics launches first histotripsy programmes in Hong Kong
HistoSonics has announced the company’s initial partnership in Asia with Hong Kong University receiving their first histotripsy system following a donation from the Li...
First UK NHS hospital to use AI-enhanced treatment overcomes “Achilles’ heel”...
In the final months of 2023, the Addenbrooke Hospital in Cambridge, UK, were reported as the first UK National Health Service (NHS) facility to...
#HOPE4LIVER trial demonstrates safety and efficacy of histotripsy for liver tumours
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2023 annual meeting (9–13 September, Copenhagen, Denmark) played host to another FIRST@CIRSE session, which saw...
Sirtex Medical announces Magle Group EmboCept S collaboration agreement
Sirtex Medical, a leading manufacturer of interventional treatment solutions, has announced the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group,...
Sirtex Medical and Grand Pharmaceutical Group Limited granted NDA approval of...
Sirtex Medical has announced with Grand Pharmaceutical Group Limited, that SIR-Spheres Y-90 resin microspheres have been approved by the national medical products administration (NMPA)...
How SIR-Spheres® Y-90 resin microspheres can improve patient outcomes, offer greater...
This advertorial is sponsored by Sirtex Medical.
Two experts in the field of interventional radiology, Bernhard Gebauer (head of interventional radiology at Charité – Universitätsmedizin...
